NASDAQ:DXTR

Dextera Surgical (DXTR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.04
$0.06
50-Day Range
N/A
52-Week Range
$0.02
$0.80
Volume
1.49 million shs
Average Volume
423,525 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DXTR stock logo

About Dextera Surgical Stock (NASDAQ:DXTR)

Dextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.

DXTR Stock News Headlines

Surgical Technologist Salary
Intuitive Surgical Inc ISRG
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Intuitive Surgical (NASDAQ: ISRG)
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
See More Headlines
Receive DXTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dextera Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2017
Today
4/24/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:DXTR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Robert Y. Newell IV (Age 67)
    Principal Executive Officer, Chief Financial Officer, Vice President - Finance
  • Michael A. Bates (Age 57)
    Director
  • Julian Nikolchev (Age 62)
    Director

DXTR Stock Analysis - Frequently Asked Questions

How were Dextera Surgical's earnings last quarter?

Dextera Surgical (NASDAQ:DXTR) released its quarterly earnings results on Thursday, November, 9th. The medical instruments supplier reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by $0.02. The medical instruments supplier had revenue of $0.69 million for the quarter, compared to analyst estimates of $0.62 million.

What other stocks do shareholders of Dextera Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dextera Surgical investors own include Conatus Pharmaceuticals (CNAT), (CASC) (CASC), Vaxart (VXRT), LadRx (CYTR), Synthetic Biologics (SYN), Delcath Systems (DCTHD), Rexahn Pharmaceuticals (REXN), AVEO Pharmaceuticals (AVEO), Avid Bioservices (CDMO) and Jaguar Health (JAGX).

This page (NASDAQ:DXTR) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners